Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
38.94
-0.31 (-0.79%)
At close: Jan 16, 2026, 4:00 PM EST
38.75
-0.19 (-0.49%)
After-hours: Jan 16, 2026, 6:45 PM EST
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.92 billion as of January 16, 2026. Its market cap has increased by 595.57% in one year.
Market Cap
5.92B
Enterprise Value
5.59B
1-Year Change
595.57%
Ranking
Category
Stock Price
$38.94
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.92B, an increase of 4,666.90%. That is a compound annual growth rate of 101.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 5.97B | 10.50% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.06B |
| Johnson & Johnson | 523.97B |
| AbbVie | 388.67B |
| AstraZeneca | 299.25B |
| UnitedHealth Group | 298.48B |
| Novartis AG | 278.73B |
| Merck & Co. | 271.07B |
| Novo Nordisk | 262.20B |